BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 7583999)

  • 1. The case for wide local excision and regional node dissection for high-risk cutaneous melanoma.
    Karakousis CP
    Curr Opin Gen Surg; 1993; ():303-9. PubMed ID: 7583999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional lymph node dissections in malignant melanoma.
    Lawton GP; Ariyan S
    Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
    Fisher SR
    Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of patients with intermediate thickness melanoma: current role of elective lymph node dissection.
    Cole DJ; Baron PL
    Semin Oncol; 1996 Dec; 23(6):719-24. PubMed ID: 8970593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of malignant melanoma.
    Kroon BB; Nieweg OE
    Ann Chir Gynaecol; 2000; 89(3):242-50. PubMed ID: 11079795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of lymphatic outflow directed continuity dissection in melanoma surgery].
    Winter H; Aurisch R; Küchler I
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():115-7. PubMed ID: 9101803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The case for minimal margins and delayed regional node dissection for high-risk cutaneous melanoma.
    Cascinelli N; Belli F
    Curr Opin Gen Surg; 1993; ():310-5. PubMed ID: 7584000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
    Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
    Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
    Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
    Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.
    van Akkooi AC; Bouwhuis MG; de Wilt JH; Kliffen M; Schmitz PI; Eggermont AM
    Br J Surg; 2007 Oct; 94(10):1293-9. PubMed ID: 17702089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognosis after sentinel node biopsy in malignant melanoma].
    Lock-Andersen J; Horn J; Sjøstrand H
    Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of elective lymph node excision in melanoma of the trunk].
    Zimmermann T; Buhr J; Kelm C; Padberg W
    Zentralbl Chir; 1996; 121(6):478-82. PubMed ID: 8767335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node biopsy in melanoma patients: the medical oncologist's perspective.
    Queirolo P; Taveggia P; Gipponi M; Sertoli MR
    J Surg Oncol; 2004 Mar; 85(3):162-5. PubMed ID: 14991888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma.
    McCarthy WH; Shaw HM; Milton GW
    Surg Gynecol Obstet; 1985 Dec; 161(6):575-80. PubMed ID: 4071371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous melanoma: therapeutic lymph node and elective lymph node dissections, lymphatic mapping, and sentinel lymph node biopsy.
    Pharis DB
    Dermatol Ther; 2005; 18(6):397-406. PubMed ID: 16297015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The optimum excision margin and regional node management for primary cutaneous T3 melanomas (2-4 mm in Thickness): a retrospective study of 1587 patients treated at a single center.
    Lamboo LG; Haydu LE; Scolyer RA; Quinn MJ; Saw RP; Shannon KF; Spillane AJ; Stretch JR; Bonenkamp JJ; Thompson JF
    Ann Surg; 2014 Dec; 260(6):1095-102. PubMed ID: 25072430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.